Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)
40.80
-0.06 (-0.15%)
Jan 23, 2026, 3:00 PM CST
Assure Tech (Hangzhou) Revenue
Assure Tech (Hangzhou) had revenue of 95.54M CNY in the quarter ending September 30, 2025, a decrease of -38.41%. This brings the company's revenue in the last twelve months to 462.72M, down -21.64% year-over-year. In the year 2024, Assure Tech (Hangzhou) had annual revenue of 540.70M with 7.42% growth.
Revenue (ttm)
462.72M
Revenue Growth
-21.64%
P/S Ratio
11.22
Revenue / Employee
624.45K
Employees
741
Market Cap
5.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 540.70M | 37.34M | 7.42% |
| Dec 31, 2023 | 503.36M | -5.66B | -91.84% |
| Dec 31, 2022 | 6.17B | 4.58B | 287.97% |
| Dec 31, 2021 | 1.59B | 389.51M | 32.47% |
| Dec 31, 2020 | 1.20B | 989.96M | 471.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hefei Lifeon Pharmaceutical | 1.47B |
| Pulike Biological Engineering | 1.10B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| Lifecome Biochemistry | 587.04M |
| Innovita Biological Technology | 430.96M |
| Beijing Scitop Bio-tech | 351.47M |
| Obio Technology (Shanghai) Corp. | 244.64M |